Viekira Pak​​

Kathryn Dzintars, Pharm.D., BCPS
Viekira Pak​​ is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Viekira Pak: combination pack of four medications.
    • Ombitasvir/paritaprevir/ritonavir and dasabuvir
    • Indicated for treatment of hepatitis C virus (HCV) genotype 1 (1a or 1b) infection with or without the addition of ribavirin
  • Viekira Pak has been studied in patients with HIV co-infection, liver transplant recipients and those with compensated cirrhosis and/or mild hepatic impairment

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 2, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Viekira Pak​​ ID - 540656 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2017/03/02/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/all/Viekira_Pak​​ PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -